Related Experiment Videos
Adherens junction proteins in tumour progression
W Birchmeier1, J Hülsken, J Behrens
1Max-Delbrück Centre for Molecular Medicine, Berlin.
Cancer Surveys
|January 1, 1995
Summary
Loss of cell adhesion in carcinomas, often due to reduced E-cadherin, increases tumor cell mobility and invasiveness. Molecular changes impairing cell junctions drive cancer progression toward a more invasive state.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Carcinomas exhibit reduced epithelial differentiation, leading to increased tumor cell mobility and invasiveness.
- This phenomenon is frequently linked to diminished intercellular adhesion and compromised integrity of intercellular junctions.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the loss of intercellular adhesion in invasive carcinomas.
- To identify key molecular players involved in the disruption of epithelial cell junctions.
Main Methods:
- Analysis of E-cadherin expression levels in carcinoma cells.
- Investigation of interactions between beta-catenin and the APC tumor suppressor protein.
- Examination of molecular pathways affecting intercellular junction integrity.
Main Results:
- Downregulation of E-cadherin expression is a significant factor in impaired cell adhesion.
- Alterations in the interaction between beta-catenin and APC contribute to junction instability.
- Molecular disturbances in cell junctions promote carcinoma cell scattering and invasiveness.
Conclusions:
- Impaired intercellular adhesion, primarily through E-cadherin downregulation and beta-catenin/APC interactions, is crucial for carcinoma invasion.
- Targeting these molecular mechanisms may offer strategies to inhibit cancer progression and metastasis.